When primed effector T cells are already present in the tumor microenvironment, these will become activated following tumor cell death and release interferon-γ (within 24 hours), further enhancing PD-L1 expression on tumor and/or myeloid cells, which extends PD-L1 expression in the tumor microenvironment by at least several days. The gene discussed is CD274; the disease is neoplasm.